Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
Refractory status epilepticus (RSE) and superrefractory status epilepticus (SRSE) pose a difficult clinical challenge. Multiple cerebral receptor and transporter changes occur with prolonged status epilepticus leading to pharmacoresistance patterns unfavorable for conventional antiepileptics. In par...
Saved in:
Main Author: | F. A. Zeiler |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Critical Care Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2015/831260 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Updates in Refractory Status Epilepticus
by: Rohit Marawar, et al.
Published: (2018-01-01) -
Ketamine Infusion Associated with Improved Neurology in a Patient with NMDA Receptor Encephalitis
by: Michael MacMahon, et al.
Published: (2013-01-01) -
Oral Perampanel for the Treatment of Super-Refractory Status Epilepticus
by: Abdallah Rahbani, et al.
Published: (2019-01-01) -
Early Polytherapy for Probably Benzodiazepine Refractory Naïve Status Epilepticus (Stage 1 Plus)
by: Giuseppe Magro
Published: (2025-01-01) -
Resolution of Refractory Status Epilepticus With Ketamine Without Intubation in a Patient With Stroke-Like Migraine Attacks After Radiation Therapy (SMART) Syndrome
by: Kyle N. Kaneko, et al.
Published: (2025-01-01)